Paid Clinical Trials and Focus Groups by Category |
|
|
|
Conditions: Depression; Major Depressive Disorder
Interventions: Drug: F2695 SR; Drug: Placebo
Sponsor: Forest Laboratories
Recruiting - verified March 2010
Conditions: Depression; Anxiety; Fatigue; Distress
Intervention:
Sponsor: Northside Hospital, Inc.
Not yet recruiting - verified March 2010
Condition: Major Depressive Disorder
Intervention: Drug: Escitalopram
Sponsor: National Institute of Mental Health (NIMH)
Recruiting - verified March 2010
Conditions: Heart Disease; Liver Failure; Depressive Disorder; Alcoholic Neuropathy
Intervention: Other: Psychiatric and somatic examinations and ,if clinical indicated, treatment
Sponsor: Levanger Hospital
Recruiting - verified January 2010
Conditions: Parkinson's Disease; Depression
Intervention: Device: Transcranial Magnetic Stimulator
Sponsors: Beth Israel Deaconess Medical Center; Michael J. Fox Foundation for Parkinson's Research
Not yet recruiting - verified March 2010
Condition: Individuals at Risk for Depression
Interventions: Behavioral: AIM Web based intervention + surveillance; Behavioral: AIM web based intervention; Behavioral: Educational website
Sponsor: Northwestern University
Recruiting - verified March 2010
Condition: Multiple Sclerosis
Intervention:
Sponsor: Merck KGaA
Recruiting - verified March 2010
Conditions: Smoking Cessation; Depression
Interventions: Drug: varenicline; Drug: placebo
Sponsor: Pfizer
Not yet recruiting - verified February 2010
Condition: Major Depressive Disorder
Intervention: Drug: fluoxetine
Sponsor: Kaohsiung Kai-Suan Psychiatric Hospital
Completed - verified February 2010
Condition: Smoking Cessation
Interventions: Drug: Transdermal Nicotine; Drug: Placebo nicotine patch
Sponsor: University of Memphis
Completed - verified February 2010
Conditions: Depressive Disorder; Cancer
Interventions: Drug: Regular bupropion use; Drug: Regular SSRI (Selective serotonin reuptake inhibitors) use; Drug: Regular use of any other antidepressant; Drug: Regular TCA (Tricyclic antidepressants) use
Sponsor: GlaxoSmithKline
Active, not recruiting - verified February 2010
Conditions: Obsessive Compulsive Disorder; Body Dysmorphic Disorder; Tourette Syndrome; Trichotillomania; Panic Disorder; Social Phobia; Generalized Anxiety Disorder; Depression; Post-Traumatic Stress Disorder; Attention Deficit Hyperactivity Disorder; Eating Disorder
Intervention: Behavioral: Cognitive behavioral therapy (CBT)
Sponsor: Massachusetts General Hospital
Recruiting - verified February 2010
Condition: Depression
Intervention: Behavioral: Txt4Mood
Sponsor: University of California, San Francisco
Enrolling by invitation - verified March 2010
Condition: Depression
Interventions: Drug: Armodafinil; Drug: Armodafinil; Drug: Placebo
Sponsor: Cephalon
Recruiting - verified February 2010
Condition: Depression
Interventions: Drug: Armodafinil; Drug: Armodafinil; Drug: Placebo
Sponsor: Cephalon
Recruiting - verified February 2010
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention:
Sponsor: Merck KGaA
Recruiting - verified March 2010
Condition: Depression
Intervention: Drug: Buprenorphine
Sponsors: University of Pittsburgh; National Institutes of Health (NIH); Reckitt Benckiser Inc.; National Center for Research Resources (NCRR)
Not yet recruiting - verified February 2010
All Categories ... Medical Conditions » ... Fibromyalgia » ... Symptom: Depression 
Login/sign up for more tools for finding clinical trials. Login/Sign up Here
